Tyrosine Protein Kinase CSK Pipeline Report: Reviews Key Companies Involved and Enlists all their Major and Minor Projects
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and indus
(EMAILWIRE.COM, April 03, 2018 ) Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Tyrosine-protein kinase CSK also known as C-terminal Src kinase is an enzyme that, in humans, is encoded by the CSK gene. It plays an important role in the regulation of cell growth, differentiation, migration and immune response. It phosphorylates tyrosine residues located in the C-terminal tails of Src-family kinases (SFKs). To inhibit SFKs, CSK is recruited to the plasma membrane via binding to transmembrane proteins or adapter proteins located near the plasma membrane. It suppresses signaling by various surface receptors including T-cell receptor (TCR) and B-cell receptor (BCR).
Report Source: https://www.themarketreports.com/report/tyrosine-protein-kinase-csk-c-src-kinase-or-protein-tyrosine-kinase-cyl-or-csk-or-ec-27102-pipeline-review-h1-2018
Scope
• The report provides a snapshot of the global therapeutic landscape for Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2)
• The report reviews Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) targeted therapeutics and enlists all their major and minor projects
• The report assesses Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
Purchase this report at: https://www.themarketreports.com/report/buy-now/968350
List of Figures
• Number of Products under Development by Stage of Development, H1 2018
• Number of Products under Development by Therapy Areas, H1 2018
• Number of Products under Development by Top 10 Indications, H1 2018
• Number of Products by Stage and Mechanism of Actions, H1 2018
• Number of Products by Routes of Administration, H1 2018
• Number of Products by Stage and Routes of Administration, H1 2018
• Number of Products by Molecule Types, H1 2018
• Number of Products by Stage and Molecule Types, H1 2018
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/968350
Report Source: https://www.themarketreports.com/report/tyrosine-protein-kinase-csk-c-src-kinase-or-protein-tyrosine-kinase-cyl-or-csk-or-ec-27102-pipeline-review-h1-2018
Scope
• The report provides a snapshot of the global therapeutic landscape for Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2)
• The report reviews Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) targeted therapeutics and enlists all their major and minor projects
• The report assesses Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
Purchase this report at: https://www.themarketreports.com/report/buy-now/968350
List of Figures
• Number of Products under Development by Stage of Development, H1 2018
• Number of Products under Development by Therapy Areas, H1 2018
• Number of Products under Development by Top 10 Indications, H1 2018
• Number of Products by Stage and Mechanism of Actions, H1 2018
• Number of Products by Routes of Administration, H1 2018
• Number of Products by Stage and Routes of Administration, H1 2018
• Number of Products by Molecule Types, H1 2018
• Number of Products by Stage and Molecule Types, H1 2018
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/968350
Contact Information:
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
The Market Reports
Shirish Gupta
Tel: +1-631-407-1315
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results